Search Within

Brian Kushner

  1. "Biostatistics Service"
Formats
  1. Journal Article (32)
  2. Meeting Abstract (12)
  3. Conference Paper (2)
Groups
  1. Biostatistics Service (46)
  2. Epidemiology and Biostatistics (46)
  3. Neuroblastoma Service (46)
  4. Pediatrics, Department of (46)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (44)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (44)

More Groups

People
  1. Nai-Kong Cheung (44)
  2. Shakeel Modak (26)
  3. Kim Kramer (25)
  4. Ellen Basu (18)
  5. Glenn Heller (17)
  6. Irene Cheung (17)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (2)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Pediatric Blood and Cancer (10)
  3. Cancer (4)
  4. Cancer Research (3)
  5. Medical and Pediatric Oncology (3)
  6. Journal of Pediatric Surgery (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. Wiley Periodicals, Inc (10)
  3. American Association for Cancer Research (4)
  4. Wiley Blackwell (4)
  5. Wiley Liss (3)
  6. Landes Bioscience (2)

More Publishers

Results (46)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
    Journal Article

    Kushner, B. H.; Modak, S.; Mauguen, A.; Basu, E. M.; Kramer, K.; Roberts, S. S.; Cheung, I. Y.; Cheung, N. K. V.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • N9: Pilot study of novel shortened induction for high-risk neuroblastoma
    Meeting Abstract

    Kushner, B. H.; Mauguen, A.; Basu, E. M.; Cardenas, F. I.; Gerstle, J. T.; Kramer, K.; Modak, S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Ovarian function in female survivors of high-risk neuroblastoma
    Journal Article

    Jimenez-Kurlander, L.; DeRosa, A.; Kostrzewa, C. E.; Moskowitz, C. S.; Bogardus, K.; Antal, Z.; Wolden, S.; La Quaglia, M. P.; Basu, E. M.; Cardenas, F. I.; more...
    Pediatric Blood and Cancer (2024)

    Fulltext@MSK | Save
  • Long prime-boost interval and heightened anti-GD2 antibody response to carbohydrate cancer vaccine
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Basu, E. M.; Feng, Y.; Kushner, B. H.; Cheung, N. K.
    Vaccines (2024)

    Fulltext@MSK | Save
  • Gut microbiota associations with GD2/GD3 vaccine response in patients with high-risk neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Nguyen, C.; Cheung, I.; Kushner, B.; Mauguen, A.; Waters, N.; Dai, A.; Kivovich, V.; Littmann, E.; Harford, L.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Effect of oral β-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: A phase 2 randomized clinical trial
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Ragupathi, G.; Basu, E. M.; Roberts, S. S.; Kushner, B. H.; Cheung, N. K.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Oral beta-glucan enhanced anti-ganglioside antibody titer after vaccination against high- risk neuroblastoma: Results of a randomized trial
    Meeting Abstract

    Cheung, I. Y.; Mauguen, A.; Feng, Y.; Ragupathi, G.; Basu, E.; Roberts, S. S.; Modak, S.; Kushner, B. H.; Cheung, N. K. V.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase I trial of oral yeast-derived β-glucan to enhance anti-GD2 immunotherapy of resistant high-risk neuroblastoma
    Journal Article

    Iglesias Cardenas, F.; Mauguen, A.; Cheung, I. Y.; Kramer, K.; Kushner, B. H.; Ragupathi, G.; Cheung, N. K. V.; Modak, S.
    Cancers (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression
    Journal Article

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save